Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

XRAY - DENTSPLY SIRONA Inc. Последние новости | Finranks

Home

/

XRAY

D

DENTSPLY SIRONA Inc. (XRAY)

NMS – Цена в реальном времени. Валюта: USD

11.41

-0.20 (-1.68%)

Рынок открыт: Aug 12, 2026, 12:50 PM EDT

11.52

-0.09 (-0.76%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

DENTSPLY SIRONA Q2 Earnings Call Highlights

DENTSPLY SIRONA Q2 Earnings Call Highlights

DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europe.

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.52 per share a year ago.

Dentsply Sirona Reports Second Quarter 2026 Results

Dentsply Sirona Reports Second Quarter 2026 Results

News Summary Reported net sales of $898 million Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18 Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52 Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada Repurchased 1.3 million shares of common stock during the quarter Reiterates 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2026.

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.

Видео

No Data

There is no data to display

Пресс-релизы

Dentsply Sirona Reports Second Quarter 2026 Results

Dentsply Sirona Reports Second Quarter 2026 Results

News Summary Reported net sales of $898 million Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18 Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52 Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada Repurchased 1.3 million shares of common stock during the quarter Reiterates 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2026.